Contact Details
University Links
- Position
- Professor, Deputy Dean of the Faculty of Medicine – Dunedin, and Consultant Medical Oncologist
- Department
- Department of Medicine (Dunedin)
- Qualifications
- MB ChB FRACP
- Research summary
- Gastrointestinal cancers, particularly colorectal cancer; clinical trials in cancer.
- Clinical
- Gastrointestinal cancer, lymphoma, melanoma, genitourinary cancer.
Research
Clinical aspects of Colorectal Cancer and its management, as well as health services research. Collaborating with lab-based scientists on genetic aspects of cancer, treatment and toxicity, as well as immunotherapy in a variety of solid tumours.
Publications
Booth, C. M., Taylor, C., Jackson, C. G. C. A., Tregear, M., Sengar, M., Wilson, B. E., … Sullivan, R. (2026). The unfulfilled promise of effective cancer medicines priced beyond reach. Lancet Oncology, 27(11), 1347-1349. doi: 10.1016/s1470-2045(26)00533-4 Journal - Research Other
O'Reilly, S., Schiller, J. H., De Guzman, R. B., Ayodele, O., Balaban, E., Bernicker, E., … Jackson, C. G. C. A., … Abdihamid, O. (2026). Pivotal role of environmental protection agencies in Global Cancer Control. JCO Global Oncology, 12(10). doi: 10.1200/go-26-00237 Journal - Research Other
Thompson, V., Waddell, O., Glyn, T., Jackson, C. G. C. A., Frizelle, F., & Purcell, R. V. (2026). Patient-reported experiences of early-onset colorectal cancer in Aotearoa New Zealand. New Zealand Medical Journal/Te ara tika o te hauora hapori, 139(1637), 98-124. doi: 10.26635/6965.7222 Journal - Research Article
Jackson, C. G. C. A., Yip, D., & Tafuna'i, L. (2026). Regionally anchored, globally connected: Lessons from the Pacific on the cancer workforce crisis. Lancet Oncology, 27(6), 661-663. doi: 10.1016/s1470-2045(26)00231-7 Journal - Research Other
Morgan, E., Bardot, A., Langselius, O., Rutherford, M. J., Abd Elkader, H., Bennett, D., … Jackson, C. G. C. A., … Soerjomataram, I. (2026). International disruptions to cancer diagnosis and stage at presentation during the COVID-19 pandemic in 2020: An International Cancer Benchmarking Partnership (ICBP) population-based study. Lancet Oncology, 27(6), 738-750. doi: 10.1016/s1470-2045(26)00089-6 Journal - Research Article
2026
Journal - Research Article
Thompson, V., Waddell, O., Glyn, T., Jackson, C. G. C. A., Frizelle, F., & Purcell, R. V. (2026). Patient-reported experiences of early-onset colorectal cancer in Aotearoa New Zealand. New Zealand Medical Journal/Te ara tika o te hauora hapori, 139(1637), 98-124. doi: 10.26635/6965.7222
Morgan, E., Bardot, A., Langselius, O., Rutherford, M. J., Abd Elkader, H., Bennett, D., … Jackson, C. G. C. A., … Soerjomataram, I. (2026). International disruptions to cancer diagnosis and stage at presentation during the COVID-19 pandemic in 2020: An International Cancer Benchmarking Partnership (ICBP) population-based study. Lancet Oncology, 27(6), 738-750. doi: 10.1016/s1470-2045(26)00089-6
Tregear, M. L., Verduzco-Aguirre, H. C., Shkabari, B., Koven, R., Scowcroft, H., Venkatash, V., … Jackson, C. G. C. A. (2026). A common sense oncology values-to-action framework for patient-centered randomized trials in oncology. Clinical Cancer Research. Advance online publication. doi: 10.1093/jnci/djag092
Tregear, M. L., Verduzco-Aquirre, H. C., Shkabari, B., Koven, R., Scowcroft, H., Venkatash, V., … Jackson, C. G. C. A. (2026). Common sense oncology values to action: A patient led framework for randomized clinical trial design. Journal of the National Cancer Institute. Advance online publication. doi: 10.1093/jnci/djag092
Journal - Research Other
Booth, C. M., Taylor, C., Jackson, C. G. C. A., Tregear, M., Sengar, M., Wilson, B. E., … Sullivan, R. (2026). The unfulfilled promise of effective cancer medicines priced beyond reach. Lancet Oncology, 27(11), 1347-1349. doi: 10.1016/s1470-2045(26)00533-4
O'Reilly, S., Schiller, J. H., De Guzman, R. B., Ayodele, O., Balaban, E., Bernicker, E., … Jackson, C. G. C. A., … Abdihamid, O. (2026). Pivotal role of environmental protection agencies in Global Cancer Control. JCO Global Oncology, 12(10). doi: 10.1200/go-26-00237
Jackson, C. G. C. A., Yip, D., & Tafuna'i, L. (2026). Regionally anchored, globally connected: Lessons from the Pacific on the cancer workforce crisis. Lancet Oncology, 27(6), 661-663. doi: 10.1016/s1470-2045(26)00231-7
Wilson, B. E., Jackson, C., Tregear, M., & Booth, C. M. (2026). “While you are on chemotherapy ...”: Common recommendations that lack evidence and may cause harm. Journal of the National Cancer Institute, 118(3), 382-385. doi: 10.1093/jnci/djaf239
2025
Chapter in Book - Research
Jackson, C. G. C. A., & Gurney, J. (2025). Achieving seismic change in policy and practice: A New Zealand case study. In M. Giuliani, M. K. Gospodarowicz, J. D. Brierley & R. Sullivan (Eds.), Cancer systems and control for health professionals. (pp. 270-278). Hoboken, NJ: Wiley.
Journal - Research Article
Gurney, J., Ongley, D., Cameron, L., Costello, S., Davies, A., Dawkins, P., Jackson, C. G. C. A., … Stanley, J. (2025). Patterns of treatment prior to death among those with lung cancer: A national study in a universal healthcare context. Lung Cancer, 208, 108761. doi: 10.1016/j.lungcan.2025.108761
Davies, A., Stanley, J., Costello, S., Dunn, A., Dawkins, P., Jackson, C., … Gurney, J. (2025). Radiation therapy for lung cancer in Aotearoa New Zealand. Cancer Causes & Control, 36, 1719-1730. doi: 10.1007/s10552-025-02052-w
Helsby, N., Sharples, K., Kim, Y. J., Porter, D., Burns, K., Jeong, S. H., … Jackson, C., … Findlay, M. (2025). A thymine-challenge test to prospectively evaluate dihydropyrimidine dehydrogenase activity for risk of severe 5-fluorouracil-induced gastrointestinal toxicity. Cancer Chemotherapy & Pharmacology, 95, 81. doi: 10.1007/s00280-025-04804-6
Gurney, J., Ballantine, K., Chiang, A., Davies, A., Jackson, C. G. C. A., Koea, J., Stanley, J., & Macfarlane, S. (2025). Child and adolescent/young adult cancer incidence and survival for Māori in Aotearoa New Zealand. Cancer Epidemiology, 97, 102868. doi: 10.1016/j.canep.2025.102868
Gurney, J., Davies, A., Stanley, J., Dunn, A., Cameron, L., Costello, S., … Jackson, C. G. C. A. (2025). National variation in the treatment of lung cancer in a universal healthcare context. British Journal of Cancer, 133, 346-352. doi: 10.1038/s41416-025-03071-9
Hossain, S. M., Gimenez, G., Stockwell, P., Weeks, R., Almomani, S., Jones, G. T., Ratajska, M., Shuen, M., Bhat, B., … Rodger, E., Jackson, C., Chatterjee, A., & Eccles, M. R. (2025). Pre-treatment DNA methylome and transcriptome profiles correlate with melanoma response to anti-PD1 immunotherapy. Cancer Letters, 618, 217638. doi: 10.1016/j.canlet.2025.217638
Teng, A., Stanley, J., Krebs, J., Jackson, C. G. C. A., Koea, J., Scott, N., Sika-Paotonu, D., Stairmand, J., … Gurney, J. (2025). Projected increases in the prevalence of diabetes mellitus in Aotearoa New Zealand, 2020–2044. New Zealand Medical Journal/Te ara tika o te hauora hapori, 138(1608), 94-106. Retrieved from https://www.nzmj.org.nz/
Journal - Research Other
Stevens, S. X., Jackson, C. G. C. A., & Karikios, D. (2025). What is the role of common sense oncology in the Western Pacific? Lancet Regional Health: Western Pacific, 61, 101660. doi: 10.1016/j.lanwpc.2025.101660
Gurney, J., Stanley, J., Davies, A., Signal, V., Dawkins, P., Cameron, L., Costello, S., Jackson, C. G. C. A., … Whitehead, J., & Koea, J. (2025). Improving lung cancer survival outcomes for Māori. New Zealand Medical Journal/Te ara tika o te hauora hapori, 138(1618), 96-103. doi: 10.26635/6965.6947
Gurney, J., & Jackson, C. (2025). Cancer prevention: The wero we are called to meet. Journal of the Royal Society of New Zealand, 55(5), 1187-1189. doi: 10.1080/03036758.2025.2529018
2024
Journal - Research Article
Wang, D., Hung, N., Hung, T., Eden, K., Chan, W.-K., Kwan, R., … Duffull, S., Glue, P., & Jackson, C. (2024). Oral docetaxel plus encequidar: A phase 1 clinical trial. Cancer Chemotherapy & Pharmacology, 94, 475-481. doi: 10.1007/s00280-024-04674-4
Wang, D., Hughes-Medlicott, N., Klingler, L., Wang, Y., Hung, N., Duffull, S., … Glue, P., … Jackson, C. (2024). A sensitive assay for unbound docetaxel using ultrafiltration plus HPLC-MS and its application to a clinical study. Pharmaceutics, 16, 602. doi: 10.3390/pharmaceutics16050602
Wang, D., Jackson, C., Hung, N., Hung, T., Kwan, R., Chan, W.-K., … Hughes-Medlicott, N. J., Glue, P., & Duffull, S. (2024). Oral docetaxel plus encequidar: A pharmacokinetic model and evaluation against IV docetaxel. Journal of Pharmacokinetics & Pharmacodynamics, 51, 335-352. doi: 10.1007/s10928-024-09913-y
Gurney, J., Davies, A., Stanley, J., Whitehead, J., Costello, S., Dawkins, P., … Jackson, C. G. C. A., Lawrenson, R., Scott, N., & Koea, J. (2024). Equity of travel to access surgery and radiation therapy for lung cancer in New Zealand. Supportive Care in Cancer, 32, 171. doi: 10.1007/s00520-024-08375-9
Gurney, J., Davies, A., Stanley, J., Cameron, L., Costello, S., Dawkins, P., … Jackson, C. G. C. A., Lawrenson, R., Whitehead, J., & Koea, J. (2024). Access to and timeliness of lung cancer surgery, radiation therapy, and systemic therapy in New Zealand: A universal health care context. JCO Global Oncology, 10, e2300258. doi: 10.1200/GO.23.00258
Teng, A., Stanley, J., Jackson, C., Koea, J., Lao, C., Lawrenson, R., … Sika-Paotonu, D., & Gurney, J. (2024). The growing cancer burden: Age-period-cohort projections in Aotearoa New Zealand 2020-2044. Cancer Epidemiology, 89, 102535. doi: 10.1016/j.canep.2024.102535
Minhinnick, A. M., Dunn, A. H., Arabnejad, V., Paddison, J., Jackson, C. G. C. A., Pointer, S. M., Gurney, J. K., & Cameron, L. B. (2024). Use of novel national data sets to monitor chemotherapy use and outcomes: A retrospective cohort study of non-small-cell lung cancer in Aotearoa New Zealand. JCO Oncology Practice, 20(3), 401-408. doi: 10.1200/op.23.00483
Anaka, M., Chan, D., Pattison, S., Thawer, A., Franco, B., Moody, L., Jackson, C., … Singh, S. (2024). Patient priorities concerning treatment decisions for advanced neuroendocrine tumors identified by discrete choice experiments. Oncologist, 29, 227-234. doi: 10.1093/oncolo/oyad312
Journal - Research Other
Towns, C., Brockway, B., Jackson, C., & Burgess, S. (2024). Duty of care? Tobacco laws and doctors in parliament. Tobacco Control, 33(6), 699-700. doi: 10.1136/tc-2024-058983
Robb, T. J., Liu, Y., Woodhouse, B., Windahl, C., Hurley, D., McArthur, G., … Guilford, P., … Jackson, C., … Lawrence, B. (2024). Blending space and time to talk about cancer in extended reality. npj Digital Medicine, 7, 261. doi: 10.1038/s41746-024-01262-x
Signal, V., Smith, M., Costello, S., Davies, A., Dawkins, P., Jackson, C. G. C. A., Koea, J., Whitehead, J., & Gurney, J. (2024). Indigenous access to clinical services along the lung cancer treatment pathway: A review of current evidence. Cancer Causes & Control, 35, 1497-1507. doi: 10.1007/s10552-024-01904-1
Wang, D., Hung, T., Hung, N., Glue, P., Jackson, C., & Duffull, S. (2024). Optimal sample selection applied to information rich, dense data. Journal of Pharmacokinetics & Pharmacodynamics, 1, 33-37. doi: 10.1007/s10928-023-09883-7
2023
Journal - Research Article
Dai, M.-S., Chao, T.-C., Chiu, C.-F., Lu, Y.-S., Shiah, H.-S., Jackson, C. G. C. A., Hung, N., … Chao, T.-Y. (2023). Oral paclitaxel and encequidar in patients with breast cancer: A pharmacokinetic, safety, and antitumor activity study. Therapeutic Advances in Medical Oncology, 15. doi: 10.1177/17588359231183680
Jenei, K., Raymakers, A. J. N., Bayle, A., Berger-Thürmel, K., Cherla, A., Honda, K., Jackson, C. G. C. A., … Gyawali, B. (2023). Health technology assessment for cancer medicines across the G7 countries and Oceania: An international, cross-sectional study. Lancet Oncology, 24, 624-635. doi: 10.1016/S1470-2045(23)00175-4
Fitzgerald, S., Blenkiron, C., Stephens, R., Mathy, J. A., Somers-Edgar, T., Rolfe, G., … Jackson, C., Eccles, M., … Rodger, E., … Guilford, P., … Print, C. G. (2023). Dynamic ctDNA mutational complexity in patients with melanoma receiving immunotherapy. Molecular Diagnosis & Therapy, 27, 537-550. doi: 10.1007/s40291-023-00651-4
Gurney, J., Davies, A., Stanley, J., Signal, V., Costello, S., Dawkins, P., … Jackson, C., … Koea, J. (2023). Emergency presentation prior to lung cancer diagnosis: A national-level examination of disparities and survival outcomes. Lung Cancer, 179, 107174. doi: 10.1016/j.lungcan.2023.03.010
Journal - Research Other
Booth, C. M., Sengar, M., Goodman, A., Wilson, B., Aggarwal, A., Berry, S., … Jackson, C., … Gyawali, B. (2023). Common Sense Oncology: Outcomes that matter. Lancet Oncology, 24(8), 833-835. doi: 10.1016/S1470-2045(23)00319-4
Conference Contribution - Published proceedings: Abstract
Blackmore, T., Norman, K., Kidd, J., Cassim, S., Chepulis, L., Keenan, R., … Jackson, C., Stokes, T., … Lawrenson, R. (2023). Barriers and facilitators to colorectal cancer diagnosis in New Zealand: A qualitative study. Australian Journal of Primary Health, 29(4), (pp. xii). doi: 10.1071/PYv29n4abs
Other Research Output
Jackson, C. (2023, May). At the crossroads of cancer care. University of Otago, Dunedin, New Zealand. [Inaugural Professorial Lecture].
2022
Journal - Research Article
Hossain, S. M., Gimenez, G., Stockwell, P. A., Tsai, P., Print, C. G., Rys, J., … Jackson, C., Chatterjee, A., & Eccles, M. R. (2022). Innate immune checkpoint inhibitor resistance is associated with melanoma sub-types exhibiting invasive and de-differentiated gene expression signatures. Frontiers in Immunology, 13, 955063. doi: 10.3389/fimmu.2022.955063
Gurney, J. K., Dunn, A., Liu, M., Mako, M., Millar, E., Ruka, M., Crengle, S., … Jackson, C., … Sarfati, D. (2022). The impact of COVID-19 on lung cancer detection, diagnosis and treatment for Māori in Aotearoa New Zealand. New Zealand Medical Journal, 135(1556), 23-43. Retrieved from https://www.nzma.org.nz/journal
He, J., Jackson, C. G. C. A., Deva, S., Hung, T., Clarke, K., Segelov, E., … Zhi, J. (2022). Population pharmacokinetics for oral paclitaxel in patients with advanced/metastatic solid tumors. CPT: Pharmacometrics & Systems Pharmacology, 11, 867-879. doi: 10.1002/psp4.12799
McPhail, S., Swann, R., Johnson, S. A., Barclay, M. E., Abd Elkader, H., Alvi, R., … Jackson, C. G. C. A., … ICBP Module 9 Emergency Presentations Working Group. (2022). Risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission (emergency presentation): An International Cancer Benchmarking Partnership (ICBP) population-based study. Lancet Oncology, 23, 587-600. doi: 10.1016/s1470-2045(22)00127-9
Journal - Research Other
Pavlakis, N., Tincknell, G., Lim, L. E., Muro, K., Obermannova, R., Lorenzen, S., … Jackson, C., … Lordick, F. (2022). European-Australasian consensus on the management of advanced gastric and gastro-oesophageal junction cancer: Current practice and new directions. Therapeutic Advances in Medical Oncology, 14. doi: 10.1177/17588359221118874
Mason, K., Kelly, L., Jackson, C., Read, D., & Borman, B. (2022). Did new treatments contribute to a decrease in melanoma deaths? New Zealand Medical Journal, 135(1558), 90-95. Retrieved from https://journal.nzma.org.nz
Conference Contribution - Verbal presentation and other Conference outputs
Fitzgerald, S., Blenkiron, C., Somers-Edgar, T., Rolfe, G., Rykers, A., Stephens, R., … Jackson, C., Cocadiz, J. A., Zou, D., Eccles, M., Day, R., Guilford, P., … Print, C. (2022, August). Evolving genomic complexity unveiled in ctDNA analysis of melanoma patients. Verbal presentation at the Cancer Satellite Meeting: Queenstown Research Week, Queenstown, New Zealand.
Wang, D., Jackson, C., Glue, P., Hung, N., Hung, T., & Duffull, S. (2022, August-September). Exploring go/no-go with oral docetaxel plus encequidar. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) NZ Annual Scientific Meeting, Queenstown, New Zealand.
2021
Journal - Research Article
Jackson, C. G. C. A., Hung, T., Segelov, E., Barlow, P., Prenen, H., McLaren, B., Hung, N. A., Clarke, K., … Deva, S. (2021). Oral paclitaxel with encequidar compared to intravenous paclitaxel in patients with advanced cancer: A randomised crossover pharmacokinetic study. British Journal of Clinical Pharmacology, 87, 4673-4683. doi: 10.1111/bcp.14886
Millar, E., Gurney, J., Beuker, S., Goza, M., Hamilton, M.-A., Hardie, C., Jackson, C. G. C. A., … Sarfati, D. (2021). Maintaining cancer services during the COVID-19 pandemic: The Aotearoa New Zealand experience. Lancet Regional Health: Western Pacific, 11, 100172. doi: 10.1016/j.lanwpc.2021.100172
Gurney, J. K., Millar, E., Dunn, A., Pirie, R., Mako, M., Manderson, J., … Jackson, C. G. C. A., … Sarfati, D. (2021). The impact of the COVID-19 pandemic on cancer diagnosis and service access in New Zealand: A country pursuing COVID-19 elimination. Lancet Regional Health: Western Pacific, 10, 100127. doi: 10.1016/j.lanwpc.2021.100127
Morgan, E., Soerjomataram, I., Gavin, A. T., Rutherford, M. J., Gatenby, P., Bardot, A., … Jackson, C., … Arnold, M. (2021). International trends in oesophageal cancer survival by histological subtype between 1995 and 2014. Gut, 70, 234-242. doi: 10.1136/gutjnl-2020-321089
Conference Contribution - Verbal presentation and other Conference outputs
Gurney, J., Jackson, C., & Mako, M. (2021, September). Equity in cancer for Māori: Creating evidence, energy and action. Verbal presentation at the Achieving Health Equity from Research Conference [Otago Spotlight Series], Wellington, New Zealand.
2020
Journal - Research Article
Blackmore, T., Norman, K., Kidd, J., Cassim, S., Chepulis, L., Keenan, R., … Jackson, C., Stokes, T., … Lawrenson, R. (2020). Barriers and facilitators to colorectal cancer diagnosis in New Zealand: A qualitative study. BMC Family Practice, 21, 206. doi: 10.1186/s12875-020-01276-w
Zou, D., Day, R., Cocadiz, J. A., Parackal, S., Mitchell, W., Black, M. A., … Jackson, C., & Guilford, P. (2020). Circulating tumor DNA is a sensitive marker for routine monitoring of treatment response in advanced colorectal cancer. Carcinogenesis, 41(11), 1507-1517. doi: 10.1093/carcin/bgaa102
Gurney, J., Stanley, J., McLeod, M., Koea, J., Jackson, C., & Sarfati, D. (2020). Disparities in cancer-specific survival between Māori and non-Māori New Zealanders, 2007-2016. JCO Global Oncology, 6, 766-774. doi: 10.1200/go.20.00028
Segelov, E., Underhill, C., Prenen, H., Karapetis, C., Jackson, C., Nott, L., … MacIntyre, C. R. (2020). Practical considerations for treating patients with cancer in the COVID-19 pandemic. JCO Oncology Practice, 16(8), 467-482. doi: 10.1200/op.20.00229
Gurney, J., Stanley, J., Jackson, C., & Sarfati, D. (2020). Stage at diagnosis for Māori cancer patients: Disparities, similarities and data limitations. New Zealand Medical Journal, 133(1508), 43-64. Retrieved from https://www.nzma.org.nz/journal
Jackson, C. G. C. A., Bissett, I., Macfarlane, S., & Costello, S. (2020). Improving cancer services and survival in New Zealand. Journal of Cancer Policy, 23, 100216. doi: 10.1016/j.jcpo.2020.100216
Walker, S., Egan, R., Young, J., Jaye, C., & Jackson, C. (2020). A citizens' jury on euthanasia/assisted dying: Does informed deliberation change people's views? Health Expectations, 23, 388-395. doi: 10.1111/hex.13008
Journal - Research Other
Weinkove, R., McQuilten, Z. K., Adler, J., Agar, M. R., Blyth, E., Cheng, A. C., … Jackson, C., … Teh, B. W. (2020). Managing haematology and oncology patients during the COVID-19 pandemic: Interim consensus guidance. Medical Journal of Australia, 212(10), 481-489. doi: 10.5694/mja2.50607
Sarfati, D., & Jackson, C. G. C. A. (2020). Preface to the NZ series on Cancer Control. Journal of Cancer Policy, 23, 100223. doi: 10.1016/j.jcpo.2020.100223
Sarfati, D., & Jackson, C. (2020). Context of cancer control in New Zealand. Journal of Cancer Policy, 23, 100211. doi: 10.1016/j.jcpo.2019.100211
Conference Contribution - Published proceedings: Abstract
Jackson, C. G. C. A., & Sarfati, D. (2020). Achieving national cancer governance reform: Lessons from a successful academic, clinical, and community advocacy approach in New Zealand. Journal of Clinical Oncology, 38(15, Suppl.), e14131. doi: 10.1200/JCO.2020.38.15_suppl.e14131
2019
Journal - Research Article
So, Y. J., Jameson, M., Newton, V., O'Donnell, A., Jeffery, M., Jackson, C., … Wilson, M. K. (2019). Investigating strategies to improve clinical trial opportunities for patients with cancer in New Zealand: INSIGHT. New Zealand Medical Journal, 132(1498), 10-31. Retrieved from https://www.nzma.org.nz/journal
Young, J., Egan, R., Walker, S., Graham-DeMello, A., & Jackson, C. (2019). The euthanasia debate: Synthesising the evidence on New Zealander's attitudes. Kōtuitui, 14(1), 1-21. doi: 10.1080/1177083X.2018.1532915
Journal - Research Other
Gurney, J., Campbell, S., Jackson, C., & Sarfati, D. (2019). Equity by 2030: Achieving equity in survival for Māori cancer patients. New Zealand Medical Journal, 132(1506), 66-76. Retrieved from https://www.nzma.org.nz/journal
Jackson, C. G. C. A., Morris, T., Hung, N., & Hung, T. (2019). Breast milk paclitaxel excretion following intravenous chemotherapy: A case report. British Journal of Cancer, 121, 421-424. doi: 10.1038/s41416-019-0529-z
Sarfati, D., Jackson, C. G. C. A., Macfarlane, S., Bissett, I., Robson, B., Gurney, J., Kemp, R., … McMenamin, J. (2019). Cancer Care at a Crossroads: Time to make a choice. New Zealand Medical Journal, 132(1493), 6-11. Retrieved from https://www.nzma.org.nz/journal
Conference Contribution - Published proceedings: Abstract
Jackson, C. G. C. A., Deva, S., Bayston, K., McLaren, B., Barlow, P., Hung, N. A., … Hung, C.-T. (2019). An international randomized cross-over bio-equivalence study of oral paclitaxel + HM30181 compared with weekly intravenous (IV) paclitaxel in patients with advanced solid tumours. Annals of Oncology, 30(Suppl. 5), mdz244.039. doi: 10.1093/annonc/mdz244.039
Conference Contribution - Verbal presentation and other Conference outputs
Jackson, C. (2019, January-February). The changing face and changing pace of cancer care in the clinic. Verbal presentation at the Cancer Care at a Crossroads Conference, Wellington, New Zealand.
2018
Journal - Research Article
Lawrence, B., Blenkiron, C., Parker, K., Tsai, P., Fitzgerald, S., Shields, P., … Black, M., … Robinson, B., … Carroll, R., … Morrin, H., … Jackson, C., … Print, C. (2018). Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancer. npj Genomic Medicine, 3, 18. doi: 10.1038/s41525-018-0058-3
Gibbs, P., Heinemann, V., Sharma, N. K., Taieb, J., Ricke, J., Peeters, M., … Robinson, B., Jackson, C., … for the SIRFLOX and FOXFIRE Global Trial Investigators, including Perez, D. (2018). Effect of primary tumor side on survival outcomes in untreated patients with metastatic colorectal cancer when selective internal radiation therapy is added to chemotherapy: Combined analysis of two randomized controlled studies. Clinical Colorectal Cancer, 17(4), e617-e629. doi: 10.1016/j.clcc.2018.06.001
Sharples, K., Firth, M., Hinder, V., Hill, A., Jeffery, M., Sarfati, D., … Atmore, C., … Derrett, S., … Keating, J., … Jackson, C., & Findlay, M. (2018). The New Zealand PIPER Project: Colorectal cancer survival according to rurality, ethnicity and socioeconomic deprivation: Results from a retrospective cohort study. New Zealand Medical Journal, 1476(131), 24-39. Retrieved from https://www.nzma.org.nz/journal
Hill, A. G., Findlay, M. P., Burge, M. E., Jackson, C., Alfonso, P. G., Samuel, L., … Tabernero, J. (2018). Phase II study of the dual EGFR/HER3 inhibitor duligotuzumab (MEHD7945A) versus cetuximab in combination with FOLFIRI in second-line RAS wild-type metastatic colorectal cancer. Clinical Cancer Research, 24(10), 2276-2284. doi: 10.1158/1078-0432.Ccr-17-0646
Journal - Research Other
Sarfati, D., & Jackson, C. (2018). Cancer inequalities endure despite NHS reforms. BMJ, 360, k989. doi: 10.1136/bmj.k989
Conference Contribution - Published proceedings: Abstract
Fitzgerald, S., Lasham, A., Blenkiron, C., Shields, P., Rolfe, G., Stephens, R., … Jackson, C., Rodger, E., Eccles, M., Day, R., Guilford, P., … Print, C. (2018). Development of plasma genomic biomarkers for mutation detection and monitoring in New Zealand cancer patients. Proceedings of the New Zealand Society for Oncology (NZSO) Conference. Retrieved from http://www.nzsoncology.org.nz/
Conference Contribution - Poster Presentation (not in published proceedings)
Fitzgerald, S., Lasham, A., Blenkiron, C., Shields, P., Rolfe, G., Stephens, R., … Jackson, C., Rodger, E., Eccles, M., Day, R., Guilford, P., … Print, C. (2018, August). Development of plasma genomic biomarkers for mutation detection and monitoring in New Zealand cancer patients. Poster session presented at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.
Conference Contribution - Verbal presentation and other Conference outputs
Shields, N. J., Young, K. A., Jackson, C., & Young, S. L. (2018, August). Tumour cell-derived proteases contribute to antigen processing and enhance cross-presentation. Verbal presentation at the Queenstown Molecular Biology (QMB) and Australasian Society for Immunology New Zealand Branch (ASI-NZ) Joint Meeting, Queenstown, New Zealand.
2017
Journal - Research Article
Li, K., Donaldson, B., Young, V., Ward, V., Jackson, C., Baird, M., & Young, S. (2017). Adoptive cell therapy with CD4+ T helper 1 cells and CD8+ cytotoxic T cells enhances complete rejection of an established tumour, leading to generation of endogenous memory responses to non-targeted tumour epitopes. Clinical & Translational Immunology, 6(10), e160. doi: 10.1038/cti.2017.37
Segelov, E., Chan, D., Lawrence, B., Pavlakis, N., Kennecke, H. F., Jackson, C., … Singh, S. (2017). Identifying and prioritizing gaps in neuroendocrine tumor research: A modified Delphi process with patients and health care providers to set the research action plan for the newly formed Commonwealth Neuroendocrine Tumor Collaboration. Journal of Global Oncology, 3(4), 380-388. doi: 10.1200/jgo.2016.006916
Grant, M. L., Shields, N., Neumann, S., Kramer, K., Bonato, A., Jackson, C., Baird, M. A., & Young, S. L. (2017). Combining dendritic cells and B cells for presentation of oxidised tumour antigens to CD8+ T cells. Clinical & Translational Immunology, 6(7), e149. doi: 10.1038/cti.2017.28
Tiong, J., Gray, A., Jackson, C., Thompson-Fawcett, M., & Schultz, M. (2017). Audit of the association between length of time spent on diagnostic work-up and tumour stage in patients with symptomatic colon cancer. ANZ Journal of Surgery, 87(3), 138-142. doi: 10.1111/ans.12804
Journal - Research Other
Lim, Y. K., Jackson, C., Dauway, E. L., & Richter, K. K. (2017). Risk factors for adverse outcome for elderly patients undergoing curative oncological resection for gastrointestinal malignancies. Visceral Medicine, 33(4), 254-261. doi: 10.1159/000475938
Conference Contribution - Published proceedings: Abstract
Jackson, C. G. C. A., Deva, S., Bayston, K., Barlow, P., Eden, K., Hung, N., … Hung, T. (2017). An open-label, randomized cross-over bioavailability study of oral paclitaxel and HM30181 compared with weekly intravenous (IV) paclitaxel in patients with advanced solid tumours. Annals of Oncology, 28(Suppl. 10), mdx568. doi: 10.1093/annonc/mdx658
Young, S., Li, K., Baird, M., Ward, V., Jackson, C., & Ronchese, F. (2017). Adoptive cell therapy with CD4+ T helper 1 cells and CD8+ cytotoxic T cells enhances complete rejection of an established tumour. Proceedings of the 46th Australasian Society for Immunology (ASI) Annual Scientific Meeting. 134. Retrieved from http://www.asi2017.org/
Shields, N., Grant, M., Young, K., Jackson, C., & Young, S. (2017). Comparison of tumor lysate preparations for the expansion of tumor-specific T cells. Proceedings of the Third CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference. (pp. 86-87). Retrieved from http://www.cancerimmunotherapyconference.org
Segelov, E., Chan, D. L., Lawrence, B., Pavlakis, N., Kennecke, H., Jackson, C., … Singh, S. (2017). Identifying and prioritizing gaps in neuroendocrine tumor research-results of the Delphi Consensus Project of the Commonwealth Neuroendocrine Tumor Research Collaboration (CommNETS). Pancreas, 46(3), (pp. 450). doi: 10.1097/MPA.0000000000000812
Conference Contribution - Verbal presentation and other Conference outputs
Parker, K., Coats, E., Woodhouse, B., Knowlton, N., Schmiedel, O., Carroll, R., … Jackson, C., … Lawrence, B. (2017, October). The NETwork! registry: Preliminary data suggests increasing incidence in a national study of neuroendocrine cancer in New Zealand (NZ). Verbal presentation at the 19th Annual Scientific Meeting of the Australasian Gastro-Intestinal Trials Group (AGITG): Trials in Action, Cairns, Australia.
Atkinson, V., Jackson, C., Heppner, P., & Chiara Formenti, S. (2017, October). Management of brain metastases in the era of immune checkpoint blockade. Panel discussion at the New Zealand Society for Oncology (NZSO) Conference, Auckland, New Zealand.
Jackson, C. (2017, August). The changing landscape of cancer care in NZ. Verbal presentation at the 8th South General Practice Conference & Medical Exhibition (GP CME), Christchurch, New Zealand.
Jackson, C. (2017, August). Priorities for cancer care in NZ: The Cancer Society's view. Plenary presentation at the 8th South General Practice Conference & Medical Exhibition (GP CME), Christchurch, New Zealand.
2016
Journal - Research Article
Li, K., Baird, M., Yang, J., Jackson, C., Ronchese, F., & Young, S. (2016). Conditions for the generation of cytotoxic CD4+ Th cells that enhance CD8+ CTL-mediated tumor regression. Clinical & Translational Immunology, 5(8), e95. doi: 10.1038/cti.2016.46
Firth, M. J., Sharples, K. J., Hinder, V. A., Macapagal, J., Sarfati, D., Derrett, S. L., … Atmore, C., Keating, J. P., Jeffery, M., … Jackson, C. G. C. A., & Findlay, M. P. N. (2016). Methods of a national colorectal cancer cohort study: The PIPER Project. New Zealand Medical Journal, 129(1440), 25-36. Retrieved from https://www.nzma.org.nz/journal
Sarfati, D., Koczwara, B., & Jackson, C. (2016). The impact of comorbidity on cancer and its treatment. CA: A Cancer Journal for Clinicians, 66(4), 337-350. doi: 10.3322/caac.21342
Journal - Research Other
Jackson, C. G. C. A., & Sarfati, D. (2016). How 'modifiable' are 'modifiable risk factors' for cancer? New Zealand Medical Journal, 129(1447), 7-9. Retrieved from http://www.nzma.org.nz/journal
Jackson, C. G. C. A. (2016). Follow-up of cancer in New Zealand: Time to review the model of care. New Zealand Medical Journal, 129(1440), 18-21. Retrieved from https://www.nzma.org.nz/journal
Conference Contribution - Verbal presentation and other Conference outputs
Jackson, C. (2016, August-September). ORAXOL: New Zealand’s role in the development of a novel oral chemotherapy agent. Verbal presentation at the Queenstown Molecular Biology (QMB) Meetings, Nelson, New Zealand.
Jackson, C. (2016, August). Common primary care problems in patients on cancer treatments. Workshop presentation at the South General Practice Conference & Medical Exhibition (GP CME), Christchurch, New Zealand.
Jackson, C. (2016, August). A paradigm shift in the treatment of advanced melanoma. Verbal presentation at the South General Practice Conference & Medical Exhibition (GP CME), Christchurch, New Zealand.
Other Research Output
Jackson, C., Robertson, S., Richards, R., Manning, P., Young, S. & Wilkins, G. (2016, November). The future face of healthcare. Dunedin School of Medicine Lecture Series, Dunedin Public Art Gallery, New Zealand. Retrieved from http://www.otago.ac.nz/dsm/about/otago625813.html
2015
Journal - Research Article
Stairmand, J., Signal, L., Sarfati, D., Jackson, C., Batten, L., Holdaway, M., & Cunningham, C. (2015). Consideration of comorbidity in treatment decision making in multidisciplinary cancer team meetings: A systematic review. Annals of Oncology, 26, 1325-1332. doi: 10.1093/annonc/mdv025
Conference Contribution - Published proceedings: Abstract
Jackson, C. G. C. A., Sharples, K. J., Murray, M. J., Hinder, V. A., Bramley, D. M., Brown, C., Derrett, S., … Keating, J. P., … Reid, P., Sarfati, D., Secker, A., & Findlay, M. P. N. (2015). Patient presentation, quality of care, and overall survival in colorectal cancer: Results from the New Zealand PIPER Cohort Study. Journal of Clinical Oncology, 33(15, Suppl.), e17637. Retrieved from http://jco.ascopubs.org/
Grant, M. L., Jackson, C., & Young, S. L. (2015). Two heads are better than one: Dendritic cells and B cells enhance the anti-tumour immune response compared with dendritic cells alone. New Zealand Medical Journal, 128(1425). Retrieved from http://www.nzma.org.nz/journal
Hill, A. G., Findlay, M., Burge, M., Jackson, C., Alfonso, P. G., Samuel, L., … Jeffery, M., … Tabernero, J. (2015). Randomized phase II study of duligotuzumab + FOLFIRI versus cetuximab + FOLFIRI in 2nd-line patients with KRAS wild-type (wt) metastatic colorectal cancer (mCRC). Cancer Research, 75(15, Suppl.), CT-110. doi: 10.1158/1538-7445.AM2015-CT110
Conference Contribution - Poster Presentation (not in published proceedings)
Grant, M., Jackson, C., & Young, S. (2015, October). Two heads are better than one: Dendritic cells and B cells enhance the anti-tumour immune response compared with dendritic cells alone. Poster session presented at the Otago Spotlight Series: Cancer Research, Wellington, New Zealand.
Ibrahim, A., Jackson, C., Derrett, S., & Samaranayaka, A. (2015, October). Colonoscopy referral criteria in faster cancer treatment pathway for patients at Southern District Health Board. Poster session presented at the Otago Spotlight Series: Cancer Research, Wellington, New Zealand.
Conference Contribution - Verbal presentation and other Conference outputs
Jackson, C. (2015, August-September). The management of colorectal cancer in New Zealand: Outcomes from the PIPER project. Verbal presentation at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.
Jackson, C. (2015, November). Latest chemotherapeutic options for CRC. Verbal presentation at the New Zealand Society of Gastroenterology & NZNO Gastroenterology Section Annual Scientific Meeting, Rotorua, New Zealand.
Jackson, C. (2015, October). Improving patient outcomes in colorectal cancer care. Verbal presentation at the Otago Spotlight Series: Cancer Research, Wellington, New Zealand.
2014
Journal - Research Article
Jackson, C. G. C. A., Sharples, K., Thompson, P. I., O'Donnell, A., Robinson, B. A., Perez, D. J., … Findlay, M. P. (2014). Dose-intense capecitabine, oxaliplatin and bevacizumab as first line treatment for metastatic, unresectable colorectal cancer: A multi-centre phase II study. BMC Cancer, 14, 737. doi: 10.1186/1471-2407-14-737
Journal - Research Other
Jackson, C., Ehrenberg, N., Frizelle, F., Sarfati, D., Balasingham, A., Pearse, M., … Bissett, I. (2014). Rectal cancer: Future directions and priorities for treatment, research and policy in New Zealand. New Zealand Medical Journal, 127(1395). Retrieved from http://www.nzma.org.nz/journal
Jackson, C., Robinson, B., & Findlay, M. (2014). Cancer services to 2025 in New Zealand: Investing in research-driven quality care. New Zealand Medical Journal, 127(1395). Retrieved from http://www.nzma.org.nz/journal
Conference Contribution - Verbal presentation and other Conference outputs
Jackson, C. (2014, October). Colorectal cancer in New Zealand: The PIPER Project. Verbal presentation at the New Zealand Society for Oncology (NZSO) Conference, Tauranga, New Zealand.
Jackson, C. (2014, August). Survivorship in cancer. Workshop presentation at the South General Practice Conference & Medical Exhibition (GP CME), Dunedin, New Zealand.
Jackson, C. (2014, August). The impact of malignancy. Verbal presentation at the South General Practice Conference & Medical Exhibition (GP CME), Dunedin, New Zealand.
Jackson, C. (2014, August). Initiatives and challenges. Workshop presentation at the South General Practice Conference & Medical Exhibition (GP CME), Dunedin, New Zealand.
Jackson, C., Sarfati, D., & Bartlett, A. (2014, June). Colorectal cancer in NZ. Workshop presentation at the General Practice Conference & Medical Exhibition (GP CME), Rotorua, New Zealand.
Jackson, C. (2014, June). Colorectal cancer: NZ's cancer. Verbal presentation at the General Practice Conference & Medical Exhibition (GP CME), Rotorua, New Zealand.
2013
Journal - Research Article
Moorcraft, S. Y., Chau, I., Peckitt, C., Cunningham, D., Rao, S., Yim, K. L., … Jackson, C. G. C. A., … Swanton, C. (2013). Patupilone in patients with pretreated metastatic/locally recurrent colorectal cancer: Results of the Phase II CINATRA trial. Investigational New Drugs, 31(5), 1339-1344. doi: 10.1007/s10637-013-9990-3
Bidwell, S., Simpson, A., Sullivan, R., Robinson, B., Thomas, W., Jackson, C., … Clarke, T. (2013). A workforce survey of New Zealand medical oncologists. New Zealand Medical Journal, 126(1371). Retrieved from http://www.nzma.org.nz/journal
Journal - Research Other
Jackson, C., McCall, J., Robinson, B., Sharples, K., & Findlay, M. (2013). Cancer trials in New Zealand: Patients are not the problem. New Zealand Medical Journal, 126(1381). Retrieved from http://www.nzma.org.nz/journal
Conference Contribution - Published proceedings: Abstract
Grant, M., Jackson, C., & Young, S. (2013). Two heads are better than one: Can we improve T cell therapy by changing APC populations? Proceedings of the 43rd Australasian Society for Immunology (ASI) Annual Scientific Meeting. (pp. 155). Retrieved from http://www.asi2013.org/
Jackson, C. (2013). Colorectal cancer in New Zealand: The PIPER project. Proceedings of the New Zealand Society for Oncology (NZSO) Conference. Retrieved from http://www.nzsoncology.org.nz/conference_2013
Conference Contribution - Verbal presentation and other Conference outputs
Jackson, C. (2013, July). Metastatic colon and rectal cancer trial concepts. Verbal presentation at the Cancer Trials New Zealand Annual Scientific Meeting, Dunedin, New Zealand.
Jackson, C. (2013, May). Colorectal cancer. Verbal presentation at the Royal Australasian College of Surgeons (RACS) 82nd Annual Scientific Conference, Auckland, New Zealand.
2012
Journal - Research Article
Pullar, J. M., Chisholm, A., & Jackson, C. (2012). Dietary information for colorectal cancer survivors: An unmet need. New Zealand Medical Journal, 125(1356). Retrieved from http://www.nzma.org.nz/journal
Conference Contribution - Verbal presentation and other Conference outputs
Jackson, C. (2012, July). PIPER. Verbal presentation at the Cancer Trials New Zealand Annual Scientific Meeting, Auckland, New Zealand.
Jackson, C. (2012, May). Colorectal cancer in New Zealand: Stuck at the bottom of the world? Verbal presentation at the New Zealand Society for Oncology (NZSO) Conference, Wellington, New Zealand.
Jackson, C. (2012, November). Right patient, right drug, right time: Improving survival in metastatic melanoma. Verbal presentation at the New Zealand Association of Plastic Surgeons Annual Scientific Meeting, Dunedin, New Zealand.
2011
Journal - Research Article
Richter, K. K., Dempster, A., Tos, A. P. D., Premkumar, R., & Jackson, C. (2011). Challenging differential diagnosis of a wild-type gastrointestinal stromal tumour (GIST) or rare reticular perineurioma of the stomach? The role for mutational analysis. New Zealand Medical Journal, 124(1331). Retrieved from http://journal.nzma.org.nz/journal/124-1331/4583/content.pdf
Conference Contribution - Poster Presentation (not in published proceedings)
Ahmadi, O., Alfadhel, M., Allawati, H., Christie, J., McKenzie, B., Missen, S., … Vaatstra, W., Thompson-Fawcett, M., Derrett, S., Sharples, K., & Jackson, C. (2011, March). Staging and follow-up of Stage II and III colorectal cancer patients: Clinical audit at Dunedin Hospital. Poster session presented at the New Zealand Association of General Surgeons (NZAGS) Annual Scientific Meeting, New Plymouth, New Zealand.
Ahmadi, O., Song, A., Allawati, H., Alfadhel, M., Christie, J., McKenzie, B., Missen, S., Vaatstra, W., Sharples, K., Derrett, S., Thompson-Fawcett, M., & Jackson, C. (2011, March). Clinical audit of follow-up of patients with colorectal cancer after curative resection at Dunedin Hospital: Provisional results. Poster session presented at the New Zealand Association of General Surgeons (NZAGS) Conference: GI Surgery, New Plymouth, New Zealand.
2010
Journal - Research Article
Jackson, C., Sirohi, B., Cunningham, D., Horwich, A., Thomas, K., & Wotherspoon, A. (2010). Lymphocyte-predominant Hodgkin lymphoma: Clinical features and treatment outcomes from a 30-year experience. Annals of Oncology, 21(10), 2061-2068. doi: 10.1093/annonc/mdq063
Conference Contribution - Published proceedings: Abstract
Tiong, J., Jackson, C., Schlup, M., Lubcke, R., & Schultz, M. (2010). Advanced tumour stages do not correlate with therapeutic delay in colonic cancer. New Zealand Medical Journal, 123(1327). Retrieved from http://journal.nzma.org.nz/journal/123-1327/4492/content.pdf
Alfadhel, M., McKenzie, B., Ahmadi, O., Allawati, H., Christie, J., Missen, S., Song, A., … Sharples, K., Derrett, S., Thompson-Fawcett, M., & Jackson, C. (2010). Clinical audit of follow-up of patients with colorectal cancer following curative resection at Dunedin Hospital: Provisional results. New Zealand Medical Journal, 123(1327). Retrieved from http://journal.nzma.org.nz/journal/123-1327/4492/content.pdf
Pullar, J., Jackson, C., & Chisholm, A. (2010). Additional dietary information for colorectal cancer survivors. Nutrition & Dietetics. 67(Suppl. 2), (pp. 20-21). doi: 10.1261/j.1747-0080.2010.01440.x
2009
Journal - Research Article
Jackson, C., Cunningham, D., Oliveira, J., on behalf of the ESMO Guidelines Working Group. (2009). Gastric cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Annals of Oncology, 20(Suppl. 4), iv34-iv36. doi: 10.1093/annonc/mdp119
2008
Journal - Research Article
Kong, G., Jackson, C., Koh, D. M., Lewington, V., Sharma, B., Brown, G., … Cook, G. J. R. (2008). The use of 18F-FDG PET/CT in colorectal liver metastases—comparison with CT and liver MRI. European Journal of Nuclear Medicine & Molecular Imaging, 35(7), 1323-1329. doi: 10.1007/s00259-008-0743-z
Jackson, C., & Cunningham, D. (2008). Where to position monoclonal antibodies in first-line treatment of advanced colorectal cancer. European Journal of Cancer, 44, 652-662. doi: 10.1016/j.ejca.2008.01.021
2007
Journal - Research Article
Jackson, C., Mochlinski, K., & Cunningham, D. (2007). Therapeutic options in gastric cancer: Neoadjuvant chemotherapy vs postoperative chemoradiotherapy. Oncology, 21(9), 1084-1087.
Jackson, C., Starling, N., Chua, Y. J., & Cunningham, D. (2007). Pharmacotherapy for oesophagogastric cancer. Drugs, 67(17), 2539-2556.
2006
Journal - Research Article
Hung, N. A., Jackson, C., Nicholson, M., & Highton, J. (2006). Pregnancy-related polymyositis and massive perivillous fibrin deposition in the placenta: Are they pathogenetically related? Arthritis & Rheumatism, 55(1), 154-156. doi: 10.1002/art.21710
2003
Conference Contribution - Poster Presentation (not in published proceedings)
Wilbanks, S. M., McInnes, S. J., Jackson, C., McIntosh, S., Young, J., & Clark, S. J. (2003, February). Prolyl isomerase activity of the trigger factor molecular chaperone is not conserved. Poster session presented at the 28th Annual Lorne Conference on Protein Structure and Function, Lorne, Australia.
2002
Conference Contribution - Verbal presentation and other Conference outputs
Wilbanks, S. M., McInnes, S. J., Jackson, C., McIntosh, S., Young, J., & Clark, S. J. (2002, November). Prolyl isomerase activity of the trigger factor molecular chaperone is not conserved. Verbal presentation at the Microbes and Molecules Conference, Christchurch, New Zealand.